Search Results

Filter
  • 1-10 of  296 results for ""ANTI-HIV agents""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

How Would You Manage HIV Pre-exposure Prophylaxis in This Patient With Medical Comorbidities? : Grand Rounds Discussion From Beth Israel Deaconess Medical Center.

  • Authors : Libman H; Beth Israel Deaconess Medical Center, Boston, Massachusetts (H.L., D.K., R.B.B.).; Krakower D

Subjects: HIV Infections*/HIV Infections*/HIV Infections*/drug therapy ; HIV Infections*/HIV Infections*/HIV Infections*/prevention & control ; Pre-Exposure Prophylaxis*

  • Source: Annals of internal medicine [Ann Intern Med] 2024 Apr; Vol. 177 (4), pp. 518-526. Date of Electronic Publication: 2024 Apr 09.Publisher: American College of Physicians--American Society of Internal Medicine Country of Publication: United States NLM ID: 0372351 Publication Model:

Record details

×
Editorial & Opinion

Hit Me With Your Best Shot: Long-Acting Therapies to Improve HIV Viral Suppression.

  • Authors : Kimmel SD; Sections of General Internal Medicine and Infectious Diseases, Department of Medicine, Boston Medical Center, and Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts.; Wurcel AG

Subjects: Anti-HIV Agents*/Anti-HIV Agents*/Anti-HIV Agents*/therapeutic use ; HIV Infections*/HIV Infections*/HIV Infections*/drug therapy; Humans

  • Source: Annals of internal medicine [Ann Intern Med] 2023 Jul; Vol. 176 (7), pp. 1001-1002. Date of Electronic Publication: 2023 Jul 04.Publisher: American College of Physicians--American Society of Internal Medicine Country of Publication: United States NLM ID: 0372351 Publication Model:

Record details

×
Academic Journal

Demonstration Project of Long-Acting Antiretroviral Therapy in a Diverse Population of People With HIV.

  • Authors : Gandhi M; Division of HIV, Infectious Diseases and Global Medicine, Department of Medicine, University of California, San Francisco, San Francisco, California (M.G., M.H., E.I., J.G., F.M., J.D.S., J.O., M.S., J. Salazar, S.D., J.Q.N., D.V.H., K.A.C.).; Hickey M

Subjects: Anti-HIV Agents*/Anti-HIV Agents*/Anti-HIV Agents*/therapeutic use ; HIV Infections*/HIV Infections*/HIV Infections*/epidemiology; Adult

  • Source: Annals of internal medicine [Ann Intern Med] 2023 Jul; Vol. 176 (7), pp. 969-974. Date of Electronic Publication: 2023 Jul 04.Publisher: American College of Physicians--American Society of Internal Medicine Country of Publication: United States NLM ID: 0372351 Publication Model:

Record details

×
Editorial & Opinion

Determining the Most Appropriate Use of Available Regimens for HIV Preexposure Prophylaxis.

  • Authors : Holtgrave DR; School of Public Health, University at Albany, State University of New York, Albany, New York.; Valdiserri RO

Subjects: Anti-HIV Agents*/Anti-HIV Agents*/Anti-HIV Agents*/therapeutic use ; HIV Infections*/HIV Infections*/HIV Infections*/drug therapy ; HIV Infections*/HIV Infections*/HIV Infections*/prevention & control

  • Source: Annals of internal medicine [Ann Intern Med] 2022 Apr; Vol. 175 (4), pp. 600-601. Date of Electronic Publication: 2022 Feb 01.Publisher: American College of Physicians--American Society of Internal Medicine Country of Publication: United States NLM ID: 0372351 Publication Model:

Record details

×
Academic Journal

Cost-Effectiveness of Long-Acting Injectable HIV Preexposure Prophylaxis in the United States : A Cost-Effectiveness Analysis.

  • Authors : Neilan AM; Division of General Academic Pediatrics, Division of Infectious Diseases, and Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, and Harvard Medical School, Boston, Massachusetts (A.M.N.).; Landovitz RJ

Subjects: Anti-HIV Agents*/Anti-HIV Agents*/Anti-HIV Agents*/therapeutic use ; HIV Infections*/HIV Infections*/HIV Infections*/drug therapy ; Pre-Exposure Prophylaxis*

  • Source: Annals of internal medicine [Ann Intern Med] 2022 Apr; Vol. 175 (4), pp. 479-489. Date of Electronic Publication: 2022 Feb 01.Publisher: American College of Physicians--American Society of Internal Medicine Country of Publication: United States NLM ID: 0372351 Publication Model:

Record details

×
Editorial & Opinion

The Esperanza Patient: More Hope for a Sterilizing HIV-1 Cure.

  • Authors : Blankson JN; Center for AIDS Research, Department of Medicine, Johns Hopkins Medicine, Baltimore, Maryland.

Subjects: Anti-HIV Agents*/Anti-HIV Agents*/Anti-HIV Agents*/therapeutic use ; HIV Infections*/HIV Infections*/HIV Infections*/drug therapy ; HIV Seropositivity*

  • Source: Annals of internal medicine [Ann Intern Med] 2022 Jan; Vol. 175 (1), pp. 135-136. Date of Electronic Publication: 2021 Nov 16.Publisher: American College of Physicians--American Society of Internal Medicine Country of Publication: United States NLM ID: 0372351 Publication Model:

Record details

×
Academic Journal

Summary for Patients: Weight and Metabolic Changes After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living With HIV.

Subjects: Alanine/Alanine/Alanine/*therapeutic use ; Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*therapeutic use ; HIV Infections/HIV Infections/HIV Infections/*drug therapy

  • Source: Annals of internal medicine [Ann Intern Med] 2021 Jun; Vol. 174 (6), pp. I21. Date of Electronic Publication: 2021 Mar 16.Publisher: American College of Physicians--American Society of Internal Medicine Country of Publication: United States NLM ID: 0372351 Publication Model:

Record details

×
Academic Journal

Weight and Metabolic Changes After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living With HIV : A Cohort Study.

Subjects: Alanine/Alanine/Alanine/*therapeutic use ; Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*therapeutic use ; HIV Infections/HIV Infections/HIV Infections/*drug therapy

  • Source: Annals of internal medicine [Ann Intern Med] 2021 Jun; Vol. 174 (6), pp. 758-767. Date of Electronic Publication: 2021 Mar 16.Publisher: American College of Physicians--American Society of Internal Medicine Country of Publication: United States NLM ID: 0372351 Publication Model:

Record details

×
Academic Journal

National Trends in Drug Payments for HIV Preexposure Prophylaxis in the United States, 2014 to 2018 : A Retrospective Cohort Study.

  • Authors : Furukawa NW; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia (N.W.F., W.Z., Y.A.H., R.K.S., K.W.H.).; Zhu W

Subjects: Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*economics ; Drug Prescriptions/Drug Prescriptions/Drug Prescriptions/*economics ; HIV Infections/HIV Infections/HIV Infections/*prevention & control

  • Source: Annals of internal medicine [Ann Intern Med] 2020 Nov 17; Vol. 173 (10), pp. 799-805. Date of Electronic Publication: 2020 Sep 08.Publisher: American College of Physicians--American Society of Internal Medicine Country of Publication: United States NLM ID: 0372351 Publication Model:

Record details

×
Academic Journal

Payments for Preexposure Prophylaxis in the United States: Too Much for Too Few.

  • Authors : Ard KL; Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts (K.L.A., R.P.W.).; Walensky RP

Subjects: Anti-HIV Agents*/Anti-HIV Agents*/Anti-HIV Agents*/therapeutic use ; HIV Infections*/HIV Infections*/HIV Infections*/drug therapy ; HIV Infections*/HIV Infections*/HIV Infections*/prevention & control

  • Source: Annals of internal medicine [Ann Intern Med] 2020 Nov 17; Vol. 173 (10), pp. 844-845. Date of Electronic Publication: 2020 Sep 08.Publisher: American College of Physicians--American Society of Internal Medicine Country of Publication: United States NLM ID: 0372351 Publication Model:

Record details

×
  • 1-10 of  296 results for ""ANTI-HIV agents""